Biallelic Germline DDX41 Variants in a Patient with Bone Dysplasia, Ichthyosis, and Dysmorphic Features

Overview

Journal Hum Genet

Specialty Genetics

Date 2024 Oct 25

PMID 39453476

Authors

Prashant Sharma

Jason R McFadden

F Graeme Frost

Thomas C Markello

Dorothy K Grange

Wendy J Introne

William A Gahl

May Christine V Malicdan

Affiliations

Soon will be listed here.

Abstract

DDX41 (DEAD‑box helicase 41) is a member of the largest family of RNA helicases. The DEAD-box RNA helicases share a highly conserved core structure and regulate all aspects of RNA metabolism. The functional role of DDX41 in innate immunity is also highly conserved. DDX41 acts as a sensor of viral DNA and activates the STING-TBK1-IRF3-type I IFN signaling pathway. Germline heterozygous variants in DDX41 have been reported in familial myelodysplasia syndrome (MDS)/acute myeloid leukemia (AML) patients; most patients also acquired a somatic variant in the second DDX41 allele. Here, we report a patient who inherited compound heterozygous DDX41 variants and presented with bone dysplasia, ichthyosis, and dysmorphic features. Functional analyses of the patient-derived dermal fibroblasts revealed a reduced abundance of DDX41 and abrogated activation of the IFN genes through the STING-type I interferon pathway. Genome-wide transcriptome analyses in the patient's fibroblasts revealed significant gene dysregulation and changes in the RNA splicing events. The patient's fibroblasts also displayed upregulation of periostin mRNA expression. Using an RNA binding protein assay, we identified DDX41 as a novel regulator of periostin expression. Our results suggest that functional impairment of DDX41, along with dysregulated periostin expression, likely contributes to this patient's multisystem disorder.

References

Linder P, Fuller-Pace F . Looking back on the birth of DEAD-box RNA helicases. Biochim Biophys Acta. 2013; 1829(8):750-5. DOI: 10.1016/j.bbagrm.2013.03.007. View

Gahl W, Mulvihill J, Toro C, Markello T, Wise A, Ramoni R . The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine. Mol Genet Metab. 2016; 117(4):393-400. PMC: 5560125. DOI: 10.1016/j.ymgme.2016.01.007. View

Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu Y . The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat Immunol. 2012; 14(2):172-8. PMC: 3645272. DOI: 10.1038/ni.2492. View

Chlon T, Stepanchick E, Hershberger C, Daniels N, Hueneman K, Davis A . Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia. Cell Stem Cell. 2021; 28(11):1966-1981.e6. PMC: 8571055. DOI: 10.1016/j.stem.2021.08.004. View

Talwar T, Vidhyasagar V, Qing J, Guo M, Kariem A, Lu Y . The DEAD-box protein DDX43 (HAGE) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity. J Biol Chem. 2017; 292(25):10429-10443. PMC: 5481555. DOI: 10.1074/jbc.M117.774950. View

Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S . Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 2012; 122(7):2590-600. PMC: 3386810. DOI: 10.1172/JCI58978. View

Li Q, Wang K . InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017; 100(2):267-280. PMC: 5294755. DOI: 10.1016/j.ajhg.2017.01.004. View

Bourgeois C, Mortreux F, Auboeuf D . The multiple functions of RNA helicases as drivers and regulators of gene expression. Nat Rev Mol Cell Biol. 2016; 17(7):426-38. DOI: 10.1038/nrm.2016.50. View

Makishima H, Saiki R, Nannya Y, Korotev S, Gurnari C, Takeda J . Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2022; 141(5):534-549. PMC: 10935555. DOI: 10.1182/blood.2022018221. View

10.

Gahl W, Markello T, Toro C, Fajardo K, Sincan M, Gill F . The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med. 2012; 14(1):51-9. PMC: 4098846. DOI: 10.1038/gim.0b013e318232a005. View

11.

Diness B, Risom L, Frandsen T, Hansen B, Andersen M, Schmiegelow K . Putative new childhood leukemia cancer predisposition syndrome caused by germline bi-allelic missense mutations in DDX41. Genes Chromosomes Cancer. 2018; 57(12):670-674. DOI: 10.1002/gcc.22680. View

12.

Teer J, Bonnycastle L, Chines P, Hansen N, Aoyama N, Swift A . Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res. 2010; 20(10):1420-31. PMC: 2945191. DOI: 10.1101/gr.106716.110. View

13.

Sharma P, Reichert M, Lu Y, Markello T, Adams D, Steinbach P . Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype. PLoS Genet. 2019; 15(5):e1008143. PMC: 6534290. DOI: 10.1371/journal.pgen.1008143. View

14.

Sebert M, Passet M, Raimbault A, Rahme R, Raffoux E, Sicre de Fontbrune F . Germline DDX41 mutations define a significant entity within adult MDS/AML patients. Blood. 2019; 134(17):1441-1444. DOI: 10.1182/blood.2019000909. View

15.

Quesada A, Routbort M, DiNardo C, Bueso-Ramos C, Kanagal-Shamanna R, Khoury J . DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol. 2019; 94(7):757-766. DOI: 10.1002/ajh.25486. View

16.

Parvatiyar K, Zhang Z, Teles R, Ouyang S, Jiang Y, Iyer S . The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol. 2012; 13(12):1155-61. PMC: 3501571. DOI: 10.1038/ni.2460. View

17.

Kim K, Ong F, Sasaki K . Current Understanding of Mutations in Myeloid Neoplasms. Cancers (Basel). 2023; 15(2). PMC: 9857085. DOI: 10.3390/cancers15020344. View

18.

Jiang Y, Zhu Y, Qiu W, Liu Y, Cheng G, Liu Z . Structural and functional analyses of human DDX41 DEAD domain. Protein Cell. 2016; 8(1):72-76. PMC: 5233616. DOI: 10.1007/s13238-016-0351-9. View

19.

Abdul-Ghani M, Hartman K, Ngsee J . Abstrakt interacts with and regulates the expression of sorting nexin-2. J Cell Physiol. 2005; 204(1):210-8. PMC: 2963638. DOI: 10.1002/jcp.20285. View

20.

Yamaguchi Y . Periostin in Skin Tissue Skin-Related Diseases. Allergol Int. 2017; 63(2):161-170. DOI: 10.2332/allergolint.13-RAI-0685. View